Quantcast

Latest fibrosis Stories

2014-05-16 08:24:21

Now includes information about InterMune's Expanded Access Program CHICAGO, May 16, 2014 /PRNewswire/ -- The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone. "The Pulmonary Fibrosis Foundation (PFF) is committed to serve as an impartial resource for the PF community,"...

2014-04-28 10:15:29

Inflammation has long been considered an integral part of the biological process that leads to deadly scarring in idiopathic pulmonary fibrosis. New research at National Jewish Health, however, suggests that a little inflammation may also be crucial to the healing and repair processes in the lungs.  Elizabeth Redente, PhD, assistant professor of cell biology at National Jewish Health, and her colleagues report in the April 2014 issue of the American Journal of Respiratory Cell and Molecular...

2014-04-18 13:49:48

A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma. Fibrosis, or scarring, is a hallmark of the disease, and progressive tightening of the skin and lungs can lead to serious organ damage and, in some cases, death. The concept for new therapeutic options centers on findings made by Swati Bhattacharyya, PhD, research assistant professor in Medicine-Rheumatology, who identified the role...

2014-03-27 12:30:22

CHICAGO, March 27, 2014 /PRNewswire-USNewswire/ -- Patients with pulmonary fibrosis (PF), their caregivers, family members, and health care providers will now be able to access a centralized communications center. Established by the Pulmonary Fibrosis Foundation (PFF), the leading pulmonary fibrosis patient advocacy organization, the PFF Patient Communication Center (PCC) will be the first-ever comprehensive communication resource that will be available to the PF community. This...

2014-03-20 12:29:25

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Liver Fibrosis Global Clinical Trials Review, H2, 2013 Liver Fibrosis Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an...

2014-03-14 08:26:59

WESTBOROUGH, Mass., March 14, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced upcoming presentations at the 6th Ocular Diseases and Drug Development Conference, the 72(nd) Annual Meeting of the American Academy of Dermatology ("AAD") and the Keystone Symposia Meeting, Fibrosis:...

2014-03-05 08:28:39

WESTBOROUGH, Mass., March 5, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it has been granted a patent by the U.S. Patent and Trademark Office on its unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. The patent covers the use of sd-rxRNAs...

2014-02-26 12:24:18

Julie Halston, Lindsay Mendez, Lucas Steele, Christina Bianco, Tony Yazbeck, Liz Callaway, Robert Creighton, Cady Huffman and Rashidra Scott join Emmy and Golden Globe nominated actor Tony Danza at the Fourth Annual Broadway Belts for PFF! NEW YORK, Feb. 26, 2014 /PRNewswire-USNewswire/ -- For the fourth consecutive year Broadway's best vocal talent appeared Monday night to raise funds for the rare disease, pulmonary fibrosis (PF), and honor the memory of Associated Press theater...

2014-02-05 08:29:18

-Regulus to Develop microRNA-21 for Alport Syndrome, a Life-Threatening Orphan Kidney Disease, and microRNA-21 in Oncology, to Human Proof-of-Concept- LA JOLLA, Calif., Feb. 5, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS) announced today that it has renewed its strategic alliance with Sanofi to discover, develop, and commercialize microRNA therapeutics to focus on specific orphan disease and oncology targets. Regulus will lead development of its fibrosis...

2014-01-14 08:28:37

WESTBOROUGH, Mass., Jan. 14, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it received the Notice of Allowance from the United States Patent and Trademark Office on its unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. The patent covers the...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related